Yeji
NDA/BLA filedconf 0.70

NDA/BLA filed

$SVRA · Savara Inc
Event date
Date TBD
Sponsor runway
18 mo
$202.8M liquid

Evidence

Upon preliminary review, the FDA determined that the BLA submitted in March 2025 was not sufficiently complete to permit substantive review and requested additional data related to Chemistry, Manufacturing, and Controls (CMC).
Source: Press release · 2025-05-27View press release ↗

Comparable historical nda/bla fileds· last 5 years · same event type

TickerDrugDateOutcome
$AXSM2025-12-31unknown
$RCKTkresladi2025-10-14unknown
$ALDXreproxalap2025-07-17unknown
$ETONet-6002025-07-08unknown
$BCRXorladeyo (berotralstat)2025-05-14unknown
$CORTrelacorilant2025-03-03unknown
$ALDXreproxalap2024-11-01unknown
$AXSMaxs-072024-09-04unknown
$RCKTkresladi2023-10-02unknown
$GERNimetelstat2023-08-21unknown

Recent insider activity· ±90 days

1 insider · 0 buys · 0 sells
Exercise
2026-03-18
Lowrance David L
Chief Financial Officer
80,684 @ $1.51$122K
Tax
2026-03-18
Lowrance David L
Chief Financial Officer
24,174 @ $5.04$122K
Exercise
2026-03-18
Lowrance David L
Chief Financial Officer
75,000 @ $1.59$119K
Tax
2026-03-18
Lowrance David L
Chief Financial Officer
23,661 @ $5.04$119K
Exercise
2026-03-18
Lowrance David L
Chief Financial Officer
130,650 @ $1.23$161K
Tax
2026-03-18
Lowrance David L
Chief Financial Officer
31,885 @ $5.04$161K
Exercise
2026-03-18
Lowrance David L
Chief Financial Officer
43,063 @ $1.11$48K
Tax
2026-03-18
Lowrance David L
Chief Financial Officer
9,485 @ $5.04$48K
Exercise
2026-03-18
Lowrance David L
Chief Financial Officer
12,500 @ $4.45$56K
Tax
2026-03-18
Lowrance David L
Chief Financial Officer
11,037 @ $5.04$56K
Exercise
2026-03-18
Lowrance David L
Chief Financial Officer
24,850 @ $3.35$83K
Tax
2026-03-18
Lowrance David L
Chief Financial Officer
16,518 @ $5.04$83K